general pharmaceuticals limited

2

general pharmaceuticals limited Company Information

Share GENERAL PHARMACEUTICALS LIMITED
Live 
MatureSmallDeclining

Company Number

05019416

Registered Address

32 woodstock grove, shepherds bush, london, W12 8LE

Industry

Wholesale of pharmaceutical goods

 

Telephone

-

Next Accounts Due

January 2025

Group Structure

View All

Directors

Ziad Tokatly20 Years

Gloria Tokatly8 Years

Shareholders

mr ziad tokatly 50%

mrs gloria tokatly 50%

general pharmaceuticals limited Estimated Valuation

£389.5k

Pomanda estimates the enterprise value of GENERAL PHARMACEUTICALS LIMITED at £389.5k based on a Turnover of £866k and 0.45x industry multiple (adjusted for size and gross margin).

general pharmaceuticals limited Estimated Valuation

£0

Pomanda estimates the enterprise value of GENERAL PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £-202.9k and a 3.53x industry multiple (adjusted for size and gross margin).

general pharmaceuticals limited Estimated Valuation

£322.5k

Pomanda estimates the enterprise value of GENERAL PHARMACEUTICALS LIMITED at £322.5k based on Net Assets of £153.1k and 2.11x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

General Pharmaceuticals Limited Overview

General Pharmaceuticals Limited is a live company located in london, W12 8LE with a Companies House number of 05019416. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in January 2004, it's largest shareholder is mr ziad tokatly with a 50% stake. General Pharmaceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £866k with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

General Pharmaceuticals Limited Health Check

Pomanda's financial health check has awarded General Pharmaceuticals Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2out of 5
positive_score

2 Strong

positive_score

2 Regular

positive_score

8 Weak

size

Size

annual sales of £866k, make it smaller than the average company (£24.6m)

£866k - General Pharmaceuticals Limited

£24.6m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -34%, show it is growing at a slower rate (4.7%)

-34% - General Pharmaceuticals Limited

4.7% - Industry AVG

production

Production

with a gross margin of 12.6%, this company has a higher cost of product (24.8%)

12.6% - General Pharmaceuticals Limited

24.8% - Industry AVG

profitability

Profitability

an operating margin of -24.6% make it less profitable than the average company (3.6%)

-24.6% - General Pharmaceuticals Limited

3.6% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (36)

2 - General Pharmaceuticals Limited

36 - Industry AVG

paystructure

Pay Structure

on an average salary of £69k, the company has an equivalent pay structure (£69k)

£69k - General Pharmaceuticals Limited

£69k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £433k, this is less efficient (£667.4k)

£433k - General Pharmaceuticals Limited

£667.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 135 days, this is later than average (60 days)

135 days - General Pharmaceuticals Limited

60 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 138 days, this is slower than average (33 days)

138 days - General Pharmaceuticals Limited

33 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 11 days, this is less than average (56 days)

11 days - General Pharmaceuticals Limited

56 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 11 weeks, this is average cash available to meet short term requirements (10 weeks)

11 weeks - General Pharmaceuticals Limited

10 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 65.2%, this is a higher level of debt than the average (58.4%)

65.2% - General Pharmaceuticals Limited

58.4% - Industry AVG

GENERAL PHARMACEUTICALS LIMITED financials

EXPORTms excel logo

General Pharmaceuticals Limited's latest turnover from April 2023 is estimated at £866 thousand and the company has net assets of £153.1 thousand. According to their latest financial statements, General Pharmaceuticals Limited has 2 employees and maintains cash reserves of £63.9 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010
Turnover865,9931,049,8692,831,2143,019,8392,034,4404,908,2623,213,2312,103,7365,273,5033,950,4485,086,8853,565,2501,373,0731,163,562
Other Income Or Grants00000000000000
Cost Of Sales756,556928,0712,492,2982,656,0671,795,9024,367,5262,866,5841,828,8254,587,3353,460,4974,504,1663,196,1931,235,3231,040,966
Gross Profit109,437121,798338,917363,772238,537540,736346,647274,910686,168489,951582,719369,057137,749122,596
Admin Expenses322,931562,734345,689454,820-273,135173,660135,720270,302892,015868,265527,168-390,656116,103110,303
Operating Profit-213,494-440,936-6,772-91,048511,672367,076210,9274,608-205,847-378,31455,551759,71321,64612,293
Interest Payable0000026,51835,24710,139000000
Interest Receivable3,7624241445723,7117592227579102,6793,1921,198884373
Pre-Tax Profit-209,732-440,512-6,628-90,476515,383341,316175,902-4,773-204,937-375,63558,743760,91222,53012,667
Tax0000-97,923-64,850-33,421000-13,511-182,619-5,858-3,547
Profit After Tax-209,732-440,512-6,628-90,476417,460276,466142,481-4,773-204,937-375,63545,232578,29316,6729,120
Dividends Paid00000000000000
Retained Profit-209,732-440,512-6,628-90,476417,460276,466142,481-4,773-204,937-375,63545,232578,29316,6729,120
Employee Costs137,925127,154119,727112,960107,833114,83099,531134,769256,305165,045202,027164,28678,52977,885
Number Of Employees22222223645422
EBITDA*-202,931-428,28129,371-53,228558,884371,585210,9278,961-201,658-374,00960,934763,02823,17214,306

* Earnings Before Interest, Tax, Depreciation and Amortisation

Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010
Tangible Assets30,78737,96848,09679,530105,5536,64711,15615,67516,75417,22421,5299,9444,5795,610
Intangible Assets00000000000000
Investments & Other00000000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets30,78737,96848,09679,530105,5536,64711,15615,67516,75417,22421,5299,9444,5795,610
Stock & work in progress23,70080,807110,598368,337199,13445,02327,10770,14958,10054,70049,22542,50046,1554,463
Trade Debtors321,795405,6901,260,897976,586654,9111,690,9261,060,613522,3691,437,8811,171,1611,255,8891,122,275291,637286,605
Group Debtors00000000000000
Misc Debtors000540,589130,699698,3661,152,950648,609000000
Cash63,942113,0770288,465855,005134,528168,8908,771294,20269,9661,001,617275,018204,361149,301
misc current assets00000000000000
total current assets409,437599,5741,371,4952,173,9771,839,7492,568,8432,409,5601,249,8981,790,1831,295,8272,306,7311,439,793542,153440,369
total assets440,224637,5421,419,5912,253,5071,945,3022,575,4902,420,7161,265,5731,806,9371,313,0512,328,2601,449,737546,732445,979
Bank overdraft000000815,945311,961000000
Bank loan00000000000000
Trade Creditors 287,093274,679616,2161,205,765772,3041,976,1601,300,608817,3841,738,0921,039,2691,678,843845,552520,840436,759
Group/Directors Accounts00000000000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities000161,586178,983116,31197,61072,156000000
total current liabilities287,093274,679616,2161,367,351951,2872,092,4712,214,1631,201,5011,738,0921,039,2691,678,843845,552520,840436,759
loans00000000000000
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00076,15393,536000000000
provisions00000000000000
total long term liabilities00076,15393,536000000000
total liabilities287,093274,679616,2161,443,5041,044,8232,092,4712,214,1631,201,5011,738,0921,039,2691,678,843845,552520,840436,759
net assets153,131362,863803,375810,003900,479483,019206,55364,07268,845273,782649,417604,18525,8929,220
total shareholders funds153,131362,863803,375810,003900,479483,019206,55364,07268,845273,782649,417604,18525,8929,220
Apr 2023Apr 2022Apr 2021Apr 2020Apr 2019Apr 2018Apr 2017Apr 2016Apr 2015Apr 2014Apr 2013Apr 2012Apr 2011Apr 2010
Operating Activities
Operating Profit-213,494-440,936-6,772-91,048511,672367,076210,9274,608-205,847-378,31455,551759,71321,64612,293
Depreciation10,56312,65536,14337,82047,2124,50904,3534,1894,3055,3833,3151,5262,013
Amortisation00000000000000
Tax0000-97,923-64,850-33,421000-13,511-182,619-5,858-3,547
Stock-57,107-29,791-257,739169,203154,11117,916-43,04212,0493,4005,4756,725-3,65541,6924,463
Debtors-83,895-855,207-256,278731,565-1,603,682175,7291,042,585-266,903266,720-84,728133,614830,6385,032286,605
Creditors12,414-341,537-589,549433,461-1,203,856675,552483,224-920,708698,823-639,574833,291324,71284,081436,759
Accruals and Deferred Income00-161,586-17,39762,67218,70125,45472,156000000
Deferred Taxes & Provisions00000000000000
Cash flow from operations-49,515115,180-207,747-537,932769,348807,343-313,359-584,737227,045-934,330740,37578,13854,671156,450
Investing Activities
capital expenditure-3,382-2,527-4,709-11,797-146,11804,519-3,274-3,7190-16,968-8,680-495-7,623
Change in Investments00000000000000
cash flow from investments-3,382-2,527-4,709-11,797-146,11804,519-3,274-3,7190-16,968-8,680-495-7,623
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00000000000000
Other Short Term Loans 00000000000000
Long term loans00000000000000
Hire Purchase and Lease Commitments00000000000000
other long term liabilities00-76,153-17,38393,536000000000
share issue0000000000000100
interest3,7624241445723,711-25,759-35,025-9,3829102,6793,1921,198884373
cash flow from financing3,762424-76,009-16,81197,247-25,759-35,025-9,3829102,6793,1921,198884473
cash and cash equivalents
cash-49,135113,077-288,465-566,540720,477-34,362160,119-285,431224,236-931,651726,59970,65755,060149,301
overdraft00000-815,945503,984311,961000000
change in cash-49,135113,077-288,465-566,540720,477781,583-343,865-597,392224,236-931,651726,59970,65755,060149,301

general pharmaceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for general pharmaceuticals limited. Get real-time insights into general pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

General Pharmaceuticals Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for general pharmaceuticals limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

general pharmaceuticals limited Ownership

GENERAL PHARMACEUTICALS LIMITED group structure

General Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

GENERAL PHARMACEUTICALS LIMITED

05019416

GENERAL PHARMACEUTICALS LIMITED Shareholders

mr ziad tokatly 50%
mrs gloria tokatly 50%

general pharmaceuticals limited directors

General Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Ziad Tokatly (Jan 2004) and Ms Gloria Tokatly (Apr 2016).

officercountryagestartendrole
Mr Ziad TokatlyUnited Kingdom49 years Jan 2004- Director
Ms Gloria TokatlyUnited Kingdom44 years Apr 2016- Director

P&L

April 2023

turnover

866k

-18%

operating profit

-213.5k

0%

gross margin

12.7%

+8.93%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

153.1k

-0.58%

total assets

440.2k

-0.31%

cash

63.9k

-0.43%

net assets

Total assets minus all liabilities

general pharmaceuticals limited company details

company number

05019416

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

January 2004

age

20

accounts

Unaudited Abridged

ultimate parent company

None

previous names

N/A

incorporated

UK

address

32 woodstock grove, shepherds bush, london, W12 8LE

last accounts submitted

April 2023

general pharmaceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to general pharmaceuticals limited. Currently there are 2 open charges and 0 have been satisfied in the past.

charges

general pharmaceuticals limited Companies House Filings - See Documents

datedescriptionview/download